Allison Johnson, MD
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Smith+Nephew at 26.1% of the total. Reporting peaked in 2023 at $187 and has fallen 65.8% since, to $64 in 2025. That places this record below the midpoint for surgery clinicians in NC, where the typical reported total is $1,719.
Across 28 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$159
- Medtronic$102
- Innocoll Pharmaceuticals Limited$53
- Myriad Genetic Laboratories, Inc.$34
- KCI USA, Inc.$32
- Merit Medical Systems Inc$30
- plus $199 from 10 others
What the payments were for
- Food & beverage$609100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 8 | $159 |
| Medtronic | 4 | $102 |
| Innocoll Pharmaceuticals Limited | 2 | $53 |
| Myriad Genetic Laboratories, Inc. | 1 | $34 |
| KCI USA, Inc. | 2 | $32 |
| Merit Medical Systems Inc | 1 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Acera Surgical, Inc. | 1 | $29 |
| Organogenesis Inc. | 1 | $25 |
| Davol Inc. | 1 | $23 |
| Kerecis Limited | 1 | $18 |
| Stryker | 1 | $18 |
| Focal Therapeutics, Inc. | 1 | $17 |
| TELA Bio, Inc. | 1 | $16 |
| Solventum Corporation | 1 | $13 |
| Olympus America Inc. | 1 | $11 |
How this compares
$609 in reported general payments places this provider in the 30th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 14 | $145 |
| Oxycodone Hcl | 44 | $131 |
Paid to pharmacies, not to this prescriber.
Other surgery in Clyde
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
- Dana PortenierDurham$702K
- Paul EnochsCary$595K
- David IannittiCharlotte$360K
- William HopeWilmington$350K
- Martyn KnowlesRaleigh$311K
- Walter BoydGreenville$311K
- Gregory StanleyCharlotte$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.